Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Cortical demyelination is a widely recognized hallmark of multiple sclerosis (MS) and correlate of disease progression and cognitive decline. The pathomechanisms initiating and driving gray matter damage are only incompletely understood. Here, we determined the infiltrating leukocyte subpopulations in 26 cortical demyelinated lesions of biopsied MS patients and assessed their contribution to cortical lesion formation in a newly developed mouse model. We find that conformation-specific anti-myelin antibodies contribute to cortical demyelination even in the absence of the classical complement pathway. T cells and natural killer cells are relevant for intracortical type 2 but dispensable for subpial type 3 lesions, whereas CCR2 + monocytes are required for both. Depleting CCR2 + monocytes in marmoset monkeys with experimental autoimmune encephalomyelitis using a novel humanized CCR2 targeting antibody translates into significantly less cortical demyelination and disease severity. We conclude that biologics depleting CCR2 + monocytes might be attractive candidates for preventing cortical lesion formation and ameliorating disease progression in MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Self-citationHomozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J. (1998) · Nature Genetics · doi:10.1038/ng0598-56 · Cited by 1,434 · cited 2×
“2D2 mice (TCR) [6], Th/+mice (IgG, kindly provided by Tobias Litzenburger, Antonio Iglesias and Hartmut Wekerle [31]), OSE double transgenic mice (TCR × IgG) [5, 26], RAG1−/− mice [37], RAG2−/− γc−/−, RAG1−/− γc, C1q−/− (kindly provided by Marina Botto [8]) and OT-II [4] mice were bred at the animal facility of the Un…”
MethodPeterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403 · cited 1×
“Three cortical lesion types have been distinguished in studies of MS pathology according to topography [7, 41]: Leukocortical lesions (type 1) encompassing deep cortical areas and subcortical white matter, intracortical lesions centered on intracortical microvessels (type 2) and subpial lesions extending from the pia…”
BackgroundInflammatory cortical demyelination in early multiple sclerosis.
Lucchinetti, C. F., Popescu, B. F. G., Bunyan, R. F., Moll, N. M., Roemer, S. F., Lassmann, H., Brück, W., Parisi, J. E., Scheithauer, B. W., Giannini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100648 · Cited by 1,103 · cited 1×
“This view has been challenged by biopsy studies of cortical demyelinated lesions, which were highly inflammatory [32] and by animal studies demonstrating the rapid resolution of cortical inflammation [35].”
BackgroundSelf-citationMeningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Howell, O. W., Reeves, C. A., Nicholas, R., Carassiti, D., Radotra, B., Gentleman, S. M., Serafini, B., Aloisi, F., Roncaroli, F., Magliozzi, R., et al. (2011) · Brain · doi:10.1093/brain/awr182 · Cited by 858
Differential roles of microglia and monocytes in the inflamed central nervous system
Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A. M., Cialic, R., Wu, P. M., Doykan, C. E., Lin, J., Cotleur, A. C., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132477 · Cited by 856
Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., & Mørk, S. J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.7.723 · Cited by 757 · cited 2×
“Three cortical lesion types have been distinguished in studies of MS pathology according to topography [7, 41]: Leukocortical lesions (type 1) encompassing deep cortical areas and subcortical white matter, intracortical lesions centered on intracortical microvessels (type 2) and subpial lesions extending from the pia…”
BackgroundA Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
Magliozzi, R., Howell, O. W., Reeves, C., Roncaroli, F., Nicholas, R., Serafini, B., Aloisi, F., & Reynolds, R. (2010) · Annals of Neurology · doi:10.1002/ana.22230 · Cited by 747 · cited 1×
“Pathogenetically, meningeal inflammatory cells might release myelino- and neurotoxic soluble mediators, which diffuse into the superficial gray matter, contributing to demyelination and the reported gradient of neuronal damage [33].”
BackgroundAn updated histological classification system for multiple sclerosis lesions
Kuhlmann, T., Ludwin, S., Prat, A., Antel, J., Brück, W., & Lassmann, H. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1653-y · Cited by 692 · cited 1×
“The remaining 19 cortical demyelinated lesions were staged active and post-demyelinating [27].”
BackgroundSelf-citationHuitinga, I., van Rooijen, N., de Groot, C. J., Uitdehaag, B. M., & Dijkstra, C. D. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.4.1025 · Cited by 506 · cited 18×
“Recent evidence has been provided that bloodderived CCR2rfp/+ monocytes give rise to highly phagocytic and inflammatory macrophages, which initiate demyelination in EAE [53].”
BackgroundInfluentialThe Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity
Croxford, A. L., Lanzinger, M., Hartmann, F. J., Schreiner, B., Mair, F., Pelczar, P., Clausen, B. E., Jung, S., Greter, M., & Becher, B. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.010 · Cited by 484
The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain
Haider, L., Zrzavy, T., Hametner, S., Höftberger, R., Bagnato, F., Grabner, G., Trattnig, S., Pfeifenbring, S., Brück, W., & Lassmann, H. (2016) · Brain · doi:10.1093/brain/awv398 · Cited by 400 · cited 1×
“The cortex is a major predilection site for demyelination in multiple sclerosis (MS) [18].”
BackgroundSelf-citationBettelli, E., Baeten, D., Jäger, A., Sobel, R. A., & Kuchroo, V. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28334 · Cited by 336 · cited 14×
“2D2 mice (TCRMOG) [6], Th/+mice (IgGMOG, kindly provided by Tobias Litzenburger, Antonio Iglesias and Hartmut Wekerle [31]), OSE double transgenic mice (TCRMOG × IgGMOG) [5, 26], RAG1−/− mice [37], RAG2−/− γc−/−, RAG1−/− γc-/-, C1q−/− (kindly provided by Marina Botto [8]) and OT-II [4] mice were bred at the animal fac…”
MethodInfluentialExtensive cortical remyelination in patients with chronic multiple sclerosis
Albert, M., Antel, J., Brück, W., & Stadelmann, C. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00043.x · Cited by 314 · cited 1×
“In postmortem brain tissue of patients with chronic MS, cortical demyelinated lesions in general and subpial cortical demyelinated lesions in particular are less inflammatory than demyelinated white matter lesions [3, 7, 28].”
BackgroundSelf-citationDisease-specific molecular events in cortical multiple sclerosis lesions
Fischer, M. T., Wimmer, I., Höftberger, R., Gerlach, S., Haider, L., Zrzavy, T., Hametner, S., Mahad, D., Binder, C. J., Krumbholz, M., et al. (2013) · Brain · doi:10.1093/brain/awt110 · Cited by 311 · cited 1×
“In addition, expression signatures characteristic of innate and adaptive immune activation can be found in cortical demyelinated lesions at autopsy [16] and subpial cortical demyelination was often associated with meningeal inflammation [21].”
BackgroundGadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis
Absinta, M., Vuolo, L., Rao, A., Nair, G., Sati, P., Cortese, I. C. M., Ohayon, J., Fenton, K., Reyes-Mantilla, M. I., Maric, D., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001587 · Cited by 296 · cited 1×
“In line, a recent imaging study demonstrated focal, long-lasting leptomeningeal contrast enhancements in postcontrast T2 weighted fluid-attenuated inversion recovery (FLAIR) MRI in MS [2].”
BackgroundTrebst, C., Lykke Sørensen, T., Kivisäkk, P., Cathcart, M. K., Hesselgesser, J., Horuk, R., Sellebjerg, F., Lassmann, H., & Ransohoff, R. M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63017-9 · Cited by 242
Merkler, D. (2006) · Brain · doi:10.1093/brain/awl135 · Cited by 222 · cited 1×
“This view has been challenged by biopsy studies of cortical demyelinated lesions, which were highly inflammatory [32] and by animal studies demonstrating the rapid resolution of cortical inflammation [35].”
BackgroundAutoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
Spadaro, M., Gerdes, L. A., Krumbholz, M., Ertl-Wagner, B., Thaler, F. S., Schuh, E., Metz, I., Blaschek, A., Dick, A., Brück, W., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000257 · Cited by 206
Self-citationBrink, B. P., Veerhuis, R., Breij, E. C. W., van der Valk, P., Dijkstra, C. D., & Bö, L. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.147 · Cited by 191
Intracortical lesions: Relevance for new MRI diagnostic criteria for multiple sclerosis
Filippi, M., Rocca, M. A., Calabrese, M., Sormani, M. P., Rinaldi, F., Perini, P., Comi, G., & Gallo, P. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ff96f6 · Cited by 172 · cited 1×
“The presence of gray matter damage has been associated with long-term physical and cognitive impairment [11] and has early prognostic relevance for the conversion to clinically definite MS [15].”
BackgroundLIEBETANZ, D., & MERKLER, D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.05.032 · Cited by 166
Self-citationLyck, R., Lécuyer, M.-A., Abadier, M., Wyss, C. B., Matti, C., Rosito, M., Enzmann, G., Zeis, T., Michel, L., García Martín, A. B., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16678639 · Cited by 75
Rodriguez, E. G., Wegner, C., Kreutzfeldt, M., Neid, K., Thal, D. R., Jürgens, T., Brück, W., Stadelmann, C., & Merkler, D. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1260-8 · Cited by 44 · cited 1×
“Finally, the quite rapid resolution of cortical inflammation and demyelination seen in animal models even after multiple intracortical cytokine injections [44] and the relative lack of neuroaxonal damage are in contrast to the widespread and ongoing cortical demyelination and the extent of neuroaxonal loss seen in MS.”
BackgroundSelf-citation
Cited by
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Self-citationLuchetti, S., Fransen, N. L., van Eden, C. G., Ramaglia, V., Mason, M., & Huitinga, I. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1818-y · Cited by 355
“Indeed, a recent study [26] showed the importance of CCR2+ monocytes that are present in mixed/active inactive MS lesions [40], in the development of cortical demyelination and disease severity in non-human primates with EAE.”
Association between pathological and MRI findings in multiple sclerosis
Filippi, M., Brück, W., Chard, D., Fazekas, F., Geurts, J. J. G., Enzinger, C., Hametner, S., Kuhlmann, T., Preziosa, P., Rovira, À., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30451-4 · Cited by 253
Self-citationAnimal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis
Bjelobaba, I., Begovic‐Kupresanin, V., Pekovic, S., & Lavrnja, I. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24224 · Cited by 181
“However, in MOG35–55- or rMOG1–125-immunized C57BL/6 mice, cortical demyelination lesions are not a regular feature of EAE (Lagumersindez-Denis et al., 2017).”
BackgroundMechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis
Correale, J., Marrodan, M., & Ysrraelit, M. C. (2019) · Biomedicines · doi:10.3390/biomedicines7010014 · Cited by 167
“subcortical white matter, and are mostly associated with meningeal i flammation [17,28,29].”
Metadata
- Authors
- Lagumersindez-Denis, N., Wrzos, C., Mack, M., Winkler, A., van der Meer, F., Reinert, M. C., Hollasch, H., Flach, A., Brühl, H., Cullen, E., Schlumbohm, C., Fuchs, E., Linington, C., Barrantes-Freer, A., Metz, I., Wegner, C., Liebetanz, D., Prinz, M., Brück, W., Stadelmann, C., & Nessler, S.
- Venue
- Acta Neuropathologica
- Published
- 2017-04-06
- Volume
- 134
- Issue
- 1
- Pages
- 15-34
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2604216076
- Cited by
- 80
- References
- 24
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.